Identifying Patients with Polycythemia Vera at Risk of Thrombosis after Hydroxyurea Initiation: The Polycythemia Vera-Advanced Integrated Models (PV-AIM) Project.
biomarkers
hydroxyurea
machine learning
polycythemia vera
real-world evidence
ruxolitinib
thromboembolic events
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
07 Jul 2023
07 Jul 2023
Historique:
received:
09
05
2023
revised:
13
06
2023
accepted:
22
06
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Patients with polycythemia vera (PV) are at significant risk of thromboembolic events (TE). The PV-AIM study used the Optum
Identifiants
pubmed: 37509564
pii: biomedicines11071925
doi: 10.3390/biomedicines11071925
pmc: PMC10377437
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Novartis Pharma AG
ID : x
Références
Am Fam Physician. 2021 Jun 1;103(11):680-687
pubmed: 34060791
Blood Cells Mol Dis. 2020 Feb;80:102368
pubmed: 31669934
J Clin Oncol. 2023 Jul 1;41(19):3534-3544
pubmed: 37126762
J Blood Med. 2019 Nov 14;10:381-390
pubmed: 31814788
Blood Cancer J. 2018 Nov 12;8(11):112
pubmed: 30420642
Haematologica. 2017 Jan;102(1):103-109
pubmed: 27686377
N Engl J Med. 2015 Jan 29;372(5):426-35
pubmed: 25629741
Cancer. 2022 Jul 1;128(13):2441-2448
pubmed: 35417564
Blood Coagul Fibrinolysis. 2016 Sep;27(6):648-52
pubmed: 26569516
Am J Hematol. 2015 May;90(5):422-8
pubmed: 25691355
Br J Haematol. 2019 Jan;184(2):176-191
pubmed: 30478826
Leukemia. 2012 Apr;26(4):563-71
pubmed: 22076463
Lancet Haematol. 2020 Mar;7(3):e226-e237
pubmed: 31982039
Ann Hematol. 2019 May;98(5):1071-1082
pubmed: 30848334
Clin Adv Hematol Oncol. 2017 Nov;15(11):848-850
pubmed: 29200417
Br J Haematol. 2016 Mar;172(5):786-93
pubmed: 26898196
Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):63-69
pubmed: 31865003
Blood. 2015 Jul 23;126(4):560-1
pubmed: 26206947
Blood Adv. 2019 Jun 11;3(11):1729-1737
pubmed: 31175128
Oncol Res Treat. 2020;43(10):526-530
pubmed: 32772025
Front Oncol. 2019 Nov 07;9:1186
pubmed: 31788449
Leukemia. 2013 Sep;27(9):1874-81
pubmed: 23739289
Lancet Oncol. 2017 Jan;18(1):88-99
pubmed: 27916398
Am J Hematol. 2022 Feb 1;97(2):E35-E37
pubmed: 34822188
Blood Cancer J. 2022 Feb 10;12(2):28
pubmed: 35145055
Lancet Haematol. 2020 Jul;7(7):e541-e550
pubmed: 32589980
Leukemia. 2022 Feb;36(2):566-568
pubmed: 34497324
Br J Haematol. 2021 Jan;192(2):239-250
pubmed: 32602593
Blood. 2016 May 19;127(20):2391-405
pubmed: 27069254
Leukemia. 2021 Feb;35(2):623-627
pubmed: 32372025
J Int Med Res. 2019 Jul;47(7):3099-3108
pubmed: 31167586
N Engl J Med. 2013 Jan 3;368(1):22-33
pubmed: 23216616
Am J Hematol. 2017 Jan;92(1):E5-E6
pubmed: 27737508
N Engl J Med. 2017 Jun 1;376(22):2168-2181
pubmed: 28564565
Haematologica. 2019 Dec;104(12):2391-2399
pubmed: 31123026
Blood Adv. 2020 Jan 28;4(2):380-386
pubmed: 31985808